NRXS
Neuraxis, INC
Key Financials
Operating Income
$-7829908
↓ 9.4%
Revenue
$3.6M
↑ 32.9%
Gross Profit
$3.0M
↑ 29.4%
Net Income
$-7800555
↑ 5.4%
EPS (Diluted)
$-0.95
↑ 22.1%
Total Assets
$6.4M
↑ 34.6%
Shareholders' Equity
$3.4M
↑ 64.4%
Total Liabilities
$3.0M
↑ 11.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 4 | 10/8/2026 | View on SEC |
| 3 | 9/29/2026 | View on SEC |
| 4 | 8/26/2026 | View on SEC |
| 4 | 8/26/2026 | View on SEC |
| 4 | 8/26/2026 | View on SEC |
| 8-K | 8/19/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NRXS |
| Company Name | Neuraxis, INC |
| CIK | 1933567 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Emerging growth company |
| Exchange | NYSE |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (812) 689-0791 |